• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 24, 2015

View Archived Issues

ProMetic partners with ProThera to develop plasma-derived IAIP

Read More

Spring Bank plans phase II trial of SB-9200 and Viread in HBV infection

Read More

University of Adelaide to conduct phase I study of AmpliPhi's AB-SA01

Read More

Galapagos begins phase I study of GLPG-1972

Read More

Daiichi Sankyo doses first subject in phase I study using Anticalin technology

Read More

Boston Pharmaceuticals launched to develop drugs for complex diseases

Read More

Autologous CBL-B-silenced cell therapy is feasible in patients with solid tumors

Read More

MediciNova to begin phase IIa study of MN-001 for hypertriglyceridemia in patients with NASH

Read More

Phase Ib trial of Aptose's APTO-253 placed on hold

Read More

Immune responses, survival improvements seen with uveal melanoma DC vaccine

Read More

Benepali is first biosimilar etanercept recommended for approval in E.U.

Read More

Vitamin D analogue DP-001 may be superior for treating secondary hyperparathyroidism

Read More

First preclinical results presented for a novel, noncovalent BTK inhibitor

Read More

CHMP recommends approval of Briviact

Read More

AstraZeneca patents ATM kinase inhibitors

Read More

Kineta discloses antiviral RIG-I pathway modulators

Read More

Bristol-Myers Squibb reports GPR40 modulators

Read More

U.S. Department of Health & Human Services introduces CB1 receptor ligands

Read More

Merck KGaA patents PARP-1/TNKS inhibitors

Read More

NEO-214 shows efficacy against gliomas

Read More

AstraZeneca sells U.S. rights to Entocort to Perrigo

Read More

Pharmacological chaperone shows promise for GM1 and Morquio B lysosomal diseases

Read More

CHMP recommends approval of Episalvan to treat partial thickness wounds in adults

Read More

Metastatic colorectal cancer study shows administration of neratinib with cetuximab is feasible

Read More

FDA clears IND for phase IIa trial of Generon's F-652 for alcoholic hepatitis

Read More

FDA approves Opdivo for renal cell carcinoma

Read More

European Commission approves Elocta for hemophilia A

Read More

European Comission grants two landmark approvals to Novartis' Consentyx

Read More

European Commission gives conditional marketing authorization to Blincyto

Read More

Gilead Sciences' Genvoya approved in E.U. for HIV-1 infection

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • U.S. Capitol building, Washington D.C.

    House passes H.R. 1, restoring R&D tax cuts

    BioWorld MedTech
    The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe